Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

LENZ Therapeutics (LENZ) Operating Margin (2025)

LENZ Therapeutics (LENZ) has disclosed Operating Margin for 1 consecutive years, with 2422.1% as the latest value for Q4 2025.

  • Quarterly Operating Margin changed N/A to 2422.1% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 477.46% through Dec 2025, changed N/A year-over-year, with the annual reading at 477.46% for FY2025, N/A changed from the prior year.
  • Operating Margin for Q4 2025 was 2422.1% at LENZ Therapeutics, down from 151.1% in the prior quarter.
  • The five-year high for Operating Margin was 151.1% in Q3 2025, with the low at 2422.1% in Q4 2025.